Report Detail
Global Enlonstobart Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706272 |
- 09 June, 2026 |
- Global |
- 81 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Enlonstobart market size was valued at US$ 29.33 million in 2025 and is forecast to a readjusted size of US$ 66.91 million by 2032 with a CAGR of 6.2% during review period.
Enlonstobart is a fully human anti‑PD‑1 monoclonal antibody and belongs to the class of immune checkpoint inhibitor anti‑tumor drugs. It specifically binds to the PD‑1 receptor on the surface of human T cells, blocks its combination with ligands, relieves the tumor‑mediated immune suppression, reactivates the body’s endogenous anti‑tumor immune response, and enhances the ability of immune cells to recognize and kill tumor tissues. With a definite anti‑tumor mechanism and controllable safety profile, this drug is clinically mainly used for the treatment of various advanced solid tumors, providing a novel immunotherapy option for tumor patients.In 2025, global Enlonstobart production reached approximately 335,294 vials.
Enlonstobart, a fully human anti-PD‑1 monoclonal antibody independently developed by CSPC Pharmaceutical Group, is an innovative drug in the field of domestic tumor immunotherapy. Relying on differentiated product characteristics and clear clinical positioning, it has gradually established unique competitive advantages in the PD‑1 inhibitor market. Approved for the second-line treatment of recurrent or metastatic cervical cancer, this drug is recommended by authoritative clinical guidelines, filling the treatment gap for specific patient groups and meeting unmet clinical needs. Endowed with low immunogenicity derived from its fully human structure, optimized safety performance and independent intellectual property rights, Enlonstobart boasts sound market expansion potential. With the continuous advancement of medical insurance access and indication expansion, its market accessibility has been further improved. Amid intensified competition and severe homogenization in the domestic PD‑1 track, it has emerged as a high-potential domestic immunotherapy agent by virtue of precise indication layout and reliable clinical efficacy. In the future, it is expected to further strengthen its market influence and industrial position through exploration of combination therapy and overseas market expansion.
This report is a detailed and comprehensive analysis for global Enlonstobart market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enlonstobart market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Enlonstobart market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Enlonstobart market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Enlonstobart market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enlonstobart
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enlonstobart market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSPC Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Enlonstobart market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100mg（10ml）/ vial
240mg（24ml）/ vial
Market segment by Combination Therapy
Combination of Enlorsumab and Gemcitabine
Combination of Enlorsumab and Bevacizumab
Market segment by Route of Administration
Intravenous Infusion
Intravenous Drip
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Recurrent Or Metastatic Cervical Cancer
Esophageal Squamous Cell Carcinoma
Advanced Solid Tumors
Others
Major players covered
CSPC Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enlonstobart product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enlonstobart, with price, sales quantity, revenue, and global market share of Enlonstobart from 2021 to 2026.
Chapter 3, the Enlonstobart competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enlonstobart breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Enlonstobart market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enlonstobart.
Chapter 14 and 15, to describe Enlonstobart sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Enlonstobart Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 100mg（10ml）/ vial
- 1.3.3 240mg（24ml）/ vial
- 1.4 Market Analysis by Combination Therapy
- 1.4.1 Overview: Global Enlonstobart Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.4.2 Combination of Enlorsumab and Gemcitabine
- 1.4.3 Combination of Enlorsumab and Bevacizumab
- 1.5 Market Analysis by Route of Administration
- 1.5.1 Overview: Global Enlonstobart Consumption Value by Route of Administration: 2021 Versus 2025 Versus 2032
- 1.5.2 Intravenous Infusion
- 1.5.3 Intravenous Drip
- 1.6 Market Analysis by Sales Channel
- 1.6.1 Overview: Global Enlonstobart Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospital
- 1.6.3 Retail
- 1.6.4 Online
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Enlonstobart Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Recurrent Or Metastatic Cervical Cancer
- 1.7.3 Esophageal Squamous Cell Carcinoma
- 1.7.4 Advanced Solid Tumors
- 1.7.5 Others
- 1.8 Global Enlonstobart Market Size & Forecast
- 1.8.1 Global Enlonstobart Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Enlonstobart Sales Quantity (2021-2032)
- 1.8.3 Global Enlonstobart Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 CSPC Pharmaceutical Group
- 2.1.1 CSPC Pharmaceutical Group Details
- 2.1.2 CSPC Pharmaceutical Group Major Business
- 2.1.3 CSPC Pharmaceutical Group Enlonstobart Product and Services
- 2.1.4 CSPC Pharmaceutical Group Enlonstobart Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 CSPC Pharmaceutical Group Recent Developments/Updates
3 Competitive Environment: Enlonstobart by Manufacturer
- 3.1 Global Enlonstobart Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Enlonstobart Revenue by Manufacturer (2021-2026)
- 3.3 Global Enlonstobart Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Enlonstobart by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Enlonstobart Manufacturer Market Share in 2025
- 3.4.3 Top 6 Enlonstobart Manufacturer Market Share in 2025
- 3.5 Enlonstobart Market: Overall Company Footprint Analysis
- 3.5.1 Enlonstobart Market: Region Footprint
- 3.5.2 Enlonstobart Market: Company Product Type Footprint
- 3.5.3 Enlonstobart Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Enlonstobart Market Size by Region
- 4.1.1 Global Enlonstobart Sales Quantity by Region (2021-2032)
- 4.1.2 Global Enlonstobart Consumption Value by Region (2021-2032)
- 4.1.3 Global Enlonstobart Average Price by Region (2021-2032)
- 4.2 North America Enlonstobart Consumption Value (2021-2032)
- 4.3 Europe Enlonstobart Consumption Value (2021-2032)
- 4.4 Asia-Pacific Enlonstobart Consumption Value (2021-2032)
- 4.5 South America Enlonstobart Consumption Value (2021-2032)
- 4.6 Middle East & Africa Enlonstobart Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Enlonstobart Sales Quantity by Type (2021-2032)
- 5.2 Global Enlonstobart Consumption Value by Type (2021-2032)
- 5.3 Global Enlonstobart Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Enlonstobart Sales Quantity by Application (2021-2032)
- 6.2 Global Enlonstobart Consumption Value by Application (2021-2032)
- 6.3 Global Enlonstobart Average Price by Application (2021-2032)
7 North America
- 7.1 North America Enlonstobart Sales Quantity by Type (2021-2032)
- 7.2 North America Enlonstobart Sales Quantity by Application (2021-2032)
- 7.3 North America Enlonstobart Market Size by Country
- 7.3.1 North America Enlonstobart Sales Quantity by Country (2021-2032)
- 7.3.2 North America Enlonstobart Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Enlonstobart Sales Quantity by Type (2021-2032)
- 8.2 Europe Enlonstobart Sales Quantity by Application (2021-2032)
- 8.3 Europe Enlonstobart Market Size by Country
- 8.3.1 Europe Enlonstobart Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Enlonstobart Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Enlonstobart Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Enlonstobart Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Enlonstobart Market Size by Region
- 9.3.1 Asia-Pacific Enlonstobart Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Enlonstobart Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Enlonstobart Sales Quantity by Type (2021-2032)
- 10.2 South America Enlonstobart Sales Quantity by Application (2021-2032)
- 10.3 South America Enlonstobart Market Size by Country
- 10.3.1 South America Enlonstobart Sales Quantity by Country (2021-2032)
- 10.3.2 South America Enlonstobart Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Enlonstobart Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Enlonstobart Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Enlonstobart Market Size by Country
- 11.3.1 Middle East & Africa Enlonstobart Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Enlonstobart Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Enlonstobart Market Drivers
- 12.2 Enlonstobart Market Restraints
- 12.3 Enlonstobart Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Enlonstobart and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Enlonstobart
- 13.3 Enlonstobart Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Enlonstobart Typical Distributors
- 14.3 Enlonstobart Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Enlonstobart. Industry analysis & Market Report on Enlonstobart is a syndicated market report, published as Global Enlonstobart Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Enlonstobart market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
